Crosstalk between Wnt/β-catenin and estrogen receptor signaling synergistically promotes osteogenic differentiation of mesenchymal progenitor cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Gao, Yanhong ^a,b   Huang, Enyi ^b,c   Zhang, Hongmei ^b,c   Wang, Jinhua ^b,c   Wu, Ningning ^b,c   Chen, Xian ^b,c   Wang, Ning ^b,d   Wen, Sheng ^b,c   Nan, Guoxin ^b,c   Deng, Fang ^b,d   Liao, Zhan ^b,e   Wu, Di ^b   Zhang, Bosi ^b   Zhang, Junhui ^b,c   Haydon, Rex C ^b   Luu, Hue H ^b   Shi, Lewis L ^b   He, Tong Chuan ^b,c  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e Central South University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; BETA CATENIN; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; T CELL FACTOR PROTEIN; TAMOXIFEN; WNT3A PROTEIN;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; ENCHONDRAL OSSIFICATION; MESENCHYMAL STEM CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; HEK293 CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; OSTEOGENESIS; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84891935212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082436     Document Type: Article

References (62)

1. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74. doi:10.1126/science. 276.5309.71. PubMed: 9082988. (Pubitemid 27161245)
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. doi:10.1126/science.284.5411.143. PubMed: 10102814. (Pubitemid 29282067)
3. Deng ZL, Sharff KA, Tang N, Song WX, Luo J et al. (2008) Regulation of osteogenic differentiation during skeletal development. Front Biosci 13: 2001-2021. doi:10.2741/2819. PubMed: 17981687. (Pubitemid 351589231)
4. Olsen BR, Reginato AM, Wang W (2000) Bone development. Annu Rev Cell Dev Biol 16: 191-220. doi:10.1146/annurev.cellbio.16.1.191. PubMed: 11031235. (Pubitemid 32037505)
5. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y et al. (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A: 1544-1552. PubMed: 12925636. (Pubitemid 36951140)
6. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG et al. (2004) Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11: 1312-1320. doi:10.1038/sj.gt. 3302298. PubMed: 15269709. (Pubitemid 39213996)
7. Luu HH, Song WX, Luo X, Manning D, Luo J et al. (2007) Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25: 665-677. doi:10.1002/jor. 20359. PubMed: 17290432. (Pubitemid 46730519)
8. Luther G, Wagner ER, Zhu G, Kang Q, Luo Q et al. (2011) BMP-9 Induced Osteogenic Differentiation of Mesenchymal Stem Cells: Molecular Mechanism and Therapeutic Potentia. Curr Gene Ther 11: 229-240. doi:10.2174/ 156652311795684777. PubMed: 21453282.
9. Tang N, Song WX, Luo J, Luo X, Chen J et al. (2009) BMP9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signaling. J Cell Mol Med 13: 2448-2464. doi:10.1111/j.1582-4934.2008.00569.x. PubMed: 19175684.
10. Si W, Kang Q, Luu HH, Park JK, Luo Q et al. (2006) CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal. Stem Cells - Mol Cell Biol 26: 2955-2964.
11. Luo Q, Kang Q, Si W, Jiang W, Park JK et al. (2004) Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal. Stem Cells - J Biol Chem 279: 55958-55968. (Pubitemid 40066603)
12. Chen L, Jiang W, Huang J, He BC, Zuo GW et al. (2010) Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res 25: 2447-2459. doi:10.1002/jbmr.133. PubMed: 20499340.
13. Zhang W, Deng ZL, Chen L, Zuo GW, Luo Q et al. (2010) Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLOS ONE 5: e11917. doi:10.1371/ journal.pone.0011917. PubMed: 20689834.
14. Liu X, Qin J, Luo Q, Bi Y, Zhu G et al. (2013) Cross-talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells. J Cell Mol Med, 17: 1160-72. PubMed: 23844832.
15. Hu N, Jiang D, Huang E, Liu X, Li R et al. (2013) BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J Cell Sci, 126: 532- 41. PubMed: 23203800.
16. Xu DJ, Zhao YZ, Wang J, He JW, Weng YG et al. (2012) Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. BMB Rep 45: 247-252. doi: 10.5483/BMBRep.2012.45.4.247. PubMed: 22531136.
17. Zhao Y, Song T, Wang W, Wang J, He J et al. (2012) P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLOS ONE 7: e43383. doi:10.1371/journal.pone. 0043383. PubMed: 22912865.
18. Wagner ER, Zhu G, Zhang BQ, Luo Q, Shi Q et al. (2011) The therapeutic potential of the Wnt signaling pathway in bone disorders. Curr Mol Pharmacol 4: 14-25. doi:10.2174/1874-470211104010014. PubMed: 20825362.
19. Kim JH, Liu X, Wang J, Chen X, Zhang H et al. (2013) Wnt signaling in bone formation and its therapeutic potential for bone diseases. Ther Adv Musculoskelet. Drosophila Inf Service 5: 13-31.
20. Nusse R, Varmus HE (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99-109. doi: 10.1016/0092-8674(82)90409-3. PubMed: 6297757.
21. Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149: 1192-1205. doi:10.1016/j.cell.2012.05.012. PubMed: 22682243.
22. He TC, Chan TA, Vogelstein B, Kinzler KW (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345. doi:10.1016/S0092-8674(00)81664-5. PubMed: 10555149. (Pubitemid 29519912)
23. He TC, Sparks AB, Rago C, Hermeking H, Zawel L et al. (1998) Identification of c-MYC as a target of the APC pathway [see comments]. Science 281: 1509-1512. doi:10.1126/science. 281.5382.1509. PubMed: 9727977. (Pubitemid 28425575)
24. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426. doi: 10.1038/18884. PubMed: 10201372. (Pubitemid 29180374)
25. Baron R, Rawadi G (2007) Wnt signaling and the regulation of bone mass. Curr Osteoporos Rep 5: 73-80. doi:10.1007/s11914-007-0006-0. PubMed: 17521509. (Pubitemid 46954745)
26. Monroe DG, McGee-Lawrence ME, Oursler MJ, Westendorf JJ (2012) Update on Wnt signaling in bone cell biology and bone disease. Gene 492: 1-18. doi:10.1016/j.gene.2011.10.044. PubMed: 22079544.
27. Williams BO, Insogna KL (2009) Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res 24: 171-178. doi: 10.1359/jbmr.081235. PubMed: 19072724.
28. Grumbach MM, Auchus RJ (1999) Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 84: 4677-4694. doi:10.1210/jc.84.12.4677. PubMed: 10599737.
29. Juul A (2001) The effects of oestrogens on linear bone growth. Hum Reprod Update 7: 303-313. doi:10.1093/humupd/7.3.303. PubMed: 11392377. (Pubitemid 32440292)
30. Simm PJ, Bajpai A, Russo VC, Werther GA (2008) Estrogens and growth. Pediatr Endocrinol Rev 6: 32-41. PubMed: 18806723.
31. Björnström L, Sjöberg M (2005) Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19: 833-842. doi:10.1210/me.2004-0486. PubMed: 15695368. (Pubitemid 40397050)
32. Burns KA, Korach KS (2012) Estrogen receptors and human disease: an update. Arch Toxicol 86: 1491-1504. doi:10.1007/ s00204-012-0868-5. PubMed: 22648069.
33. Cheskis BJ, Greger JG, Nagpal S, Freedman LP (2007) Signaling by estrogens. J Cell Physiol 213: 610-617. doi:10.1002/jcp.21253. PubMed: 17886255. (Pubitemid 350058252)
34. Matthews J, Gustafsson JA (2003) Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 3: 281-292. doi:10.1124/mi. 3.5.281. PubMed: 14993442.
35. Khosla S, Oursler MJ, Monroe DG (2012) Estrogen and the skeleton. Trends Endocrinol Metab 23: 576-581. doi:10.1016/j.tem.2012.03.008. PubMed: 22595550.
36. Huang E, Bi Y, Jiang W, Luo X, Yang K et al. (2012) Conditionally Immortalized Mouse Embryonic Fibroblasts Retain Proliferative Activity without Compromising Multipotent Differentiation Potential. PLOS ONE 7: e32428. doi:10.1371/journal.pone.0032428. PubMed: 22384246.
37. Luo X, Chen J, Song WX, Tang N, Luo J et al. (2008) Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 88: 1264-1277. doi:10.1038/labinvest. 2008.98. PubMed: 18838962.
38. Peng Y, Kang Q, Cheng H, Li X, Sun MH et al. (2003) Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 90: 1149-1165. doi:10.1002/jcb. 10744. PubMed: 14635189. (Pubitemid 37485051)
39. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514. doi:10.1073/pnas.95.5.2509. PubMed: 9482916. (Pubitemid 28145972)
40. Kang Q, Song WX, Luo Q, Tang N, Luo J et al. (2009) A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 18: 545-559. doi:10.1089/scd.2008.0130. PubMed: 18616389.
41. Luo J, Deng ZL, Luo X, Tang N, Song WX et al. (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2: 1236-1247. doi:10.1038/nprot.2007.135. PubMed: 17546019. (Pubitemid 46908240)
42. Peng Y, Kang Q, Luo Q, Jiang W, Si W et al. (2004) Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 32941-32949. doi:10.1074/ jbc.M403344200. PubMed: 15161906. (Pubitemid 39014754)
43. Sharff KA, Song WX, Luo X, Tang N, Luo J et al. (2009) Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9- induced Osteogenic Differentiation of Mesenchymal Progenitor Cells. J Biol Chem 284: 649-659. PubMed: 18986983.
44. Huang E, Zhu G, Jiang W, Yang K, Gao Y et al. (2012) Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells. J Bone Miner Res, 27: 1566-75. PubMed: 22467218.
45. Wang Y, Hong S, Li M, Zhang J, Bi Y et al. (2013) Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells. J Orthop Res, 31: 1796-803. PubMed: 23861103.
46. Huang J, Bi Y, Zhu GH, He Y, Su Y et al. (2009) Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int 29: 1569-1581. doi:10.1111/j. 1478-3231.2009.02111.x. PubMed: 19737349.
47. Zhu GH, Huang J, Bi Y, Su Y, Tang Y et al. (2009) Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation 78: 195-204. doi:10.1016/j.diff. 2009.06.001. PubMed: 19560855.
48. Rastegar F, Gao JL, Shenaq D, Luo Q, Shi Q et al. (2010) Lysophosphatidic acid acyltransferase beta (LPAATbeta) promotes the tumor growth of human osteosarcoma. PLOS ONE 5: e14182. doi: 10.1371/journal.pone.0014182. PubMed: 21152068.
49. Su Y, Wagner ER, Luo Q, Huang J, Chen L et al. (2011) Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 30: 3907-3917. doi: 10.1038/onc.2011.97. PubMed: 21460855.
50. Zhou L, An N, Haydon RC, Zhou Q, Cheng H et al. (2003) Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett 193: 161-170. doi:10.1016/ S0304-3835(03)00013-2. PubMed: 12706873. (Pubitemid 36428898)
51. Zhou L, An N, Jiang W, Haydon R, Cheng H, et al. (2002) Fluorescence-based functional assay for Wnt/beta-catenin signaling activity. Biotechniques 33: 1126-1128, passim
52. Luo Q, Kang Q, Song WX, Luu HH, Luo X et al. (2007) Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Gene 395: 160-169. doi:10.1016/j.gene.2007.02.030. PubMed: 17449199. (Pubitemid 46670640)
53. He BC, Gao JL, Zhang BQ, Luo Q, Shi Q et al. (2011) Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 79: 211-219. doi:10.1124/mol. 110.068668. PubMed: 20978119.
54. He BC, Chen L, Zuo GW, Zhang W, Bi Y et al. (2010) Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res 16: 2235-2245. doi: 10.1158/1078-0432.CCR-09-2499. PubMed: 20371684.
55. Li M, Chen Y, Bi Y, Jiang W, Luo Q et al. (2013) Establishment and characterization of the reversibly immortalized mouse fetal heart progenitors. Int J Med Sci 10: 1035-1046. doi:10.7150/ijms.6639. PubMed: 23801891.
56. Luo J, Tang M, Huang J, He BC, Gao JL et al. (2010) TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem 285: 29588-29598. doi:10.1074/jbc.M110. 130518. PubMed: 20628059.
57. de Launoit Y, Adamski J (1999) Unique multifunctional HSD17B4 gene product: 17beta-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacylcoenzyme A dehydrogenase/hydratase involved in Zellweger syndrome. J Mol Endocrinol 22: 227-240. doi:10.1677/jme.0.0220227. PubMed: 10343282. (Pubitemid 29281832)
58. Almeida M, Iyer S, Martin-Millan M, Bartell SM, Han L et al. (2013) Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest 123: 394-404. doi:10.1172/ JCI65910. PubMed: 23221342.
59. Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S et al. (2004) Wnt/beta-catenin and estrogen signaling converge in vivo. J Biol Chem 279: 40255-40258. doi:10.1074/jbc.C400331200. PubMed: 15304487. (Pubitemid 39287607)
60. Shi B, Liang J, Yang X, Wang Y, Zhao Y et al. (2007) Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol 27: 5105-5119. doi:10.1128/ MCB.00162-07. PubMed: 17502350. (Pubitemid 47068285)
61. Armstrong VJ, Muzylak M, Sunters A, Zaman G, Saxon LK et al. (2007) Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha. J Biol Chem 282: 20715-20727. doi:10.1074/jbc.M703224200. PubMed: 17491024. (Pubitemid 47100049)
62. Liedert A, Wagner L, Seefried L, Ebert R, Jakob F et al. (2010) Estrogen receptor and Wnt signaling interact to regulate early gene expression in response to mechanical strain in osteoblastic cells. Biochem Biophys Res Commun 394: 755-759. doi:10.1016/j.bbrc. 2010.03.065. PubMed: 20227388.